Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

The Blog dot

Selected category: Tecan Labwerx

Back to overview

How can custom automation accelerate commercialization of biotechnology breakthroughs?

By Domink Bell

You’ve done your testing on the benchtop and proven that your new biotechnology innovation works in your hands. Now comes the exciting part – turning your solution into a breakthrough product that is ready for broader use and commercial launch. To get there, you need to optimize your processes so that you can ensure they are robust, operate within defined tolerances, and facilitate scale-up. What’s the fastest and most efficient way to get this done so that you can focus on your next bioscience advancements?

Read more

Getting breakthrough biotechnologies to market: Why innovation is not enough

By Domink Bell

With biotechnology advancing at an astounding rate, last year’s innovations often become routine tools for today’s breakthroughs. For example, next generation sequencing (NGS) is now an integral step in CRISPR/Cas9 constructions. The interplay between hardware, software, and biotechnologies is continually in flux, as some developments see payoff more quickly than others, and emerging breakthroughs can suddenly change the game altogether. With such constant and unpredictable change, how can you ensure that your own innovations move smoothly from concept to solution as quickly as possible?

Read more
empty cart | close cart
Your cart

Your cart is empty.

Get a quote close form